文献速递新发突发、热带与寄生虫病

恶性疟原虫pfhrp2和pfhrp3基因多样性及缺失对疟疾诊断的威胁

Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria.
PubMed 文献 · Clin Microbiol Infect · 2018-09-27

本文综述了恶性疟原虫富组氨酸蛋白2(PfHRP2)和3(PfHRP3)的基因变异及基因缺失对基于PfHRP2的快速诊断试验(RDT)的影响。测序分析显示pfhrp2和pfhrp3基因存在高水平遗传变异,但基因变异似乎不是假阴性结果的主要原因;而pfhrp2基因缺失在秘鲁、圭亚那、加纳和卢旺达等国家呈现较高比例,可导致高比例假阴性结果,对疟疾控制规划构成重大威胁。

要点

  • pfhrp2基因缺失可导致基于PfHRP2的RDT出现假阴性,漏诊恶性疟原虫感染者。
  • pfhrp2和pfhrp3基因变异水平高,但基因变异似乎不是假阴性结果的主要原因。
  • 秘鲁、圭亚那、加纳和卢旺达报告了较高比例的pfhrp2阴性寄生虫。

核心结论

  • pfhrp2基因缺失导致的假阴性结果对疟疾控制规划构成重大威胁,因为感染者无法被诊断和适当治疗。
  • pfhrp2和pfhrp3基因的遗传变异似乎不是假阴性结果的主要原因。

研究设计与样本

  • 本文为综述,通过PubMed、Google Scholar和Google检索相关文献,评估疟疾流行区pfhrp2和pfhrp3基因变异或基因缺失的流行率及其对RDT使用的影响。

主要发现

  • 从PfHRP2序列中鉴定出超过18种氨基酸重复类型。
  • 测序分析显示pfhrp2和pfhrp3基因存在高水平遗传变异,在马达加斯加、尼日利亚或塞内加尔变异超过90%,且国家内和国家间均存在变异。
  • pfhrp2阴性寄生虫比例最高的国家为南美洲的秘鲁(20%-100%)和圭亚那(41%),非洲的加纳(36%)和卢旺达(23%)。
  • pfhrp2基因缺失高流行导致高比例假阴性结果。

临床怎么用

  • 在pfhrp2基因缺失高流行区,基于PfHRP2的RDT可能出现假阴性,需考虑替代诊断方法。
  • 对RDT阴性但临床高度怀疑疟疾的病例,应警惕pfhrp2基因缺失可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: PfHRP2-based rapid diagnostic tests (RDTs), based on the recognition of the Plasmodium falciparum histidine-rich protein 2, are currently the most used tests in malaria detection. Most of the antibodies used in RDTs also detect PfHRP3. However, false-negative results were reported. Significant variation in the pfhrp2 gene could lead to the expression of a modified protein that would no longer be recognized by the antibodies used in PfHRP2-based RDTs. Additionally, parasites lacking the PfHRP2 do not express the protein and are, therefore, not identifiable. AIMS: This review aims to assess the pfhrp2 and pfhrp3 genetic variation or the prevalence of gene deletion in areas where malaria is endemic and describe its implications on RDT use. SOURCES: Publications of interest were identified using PubMed, Google Scholar and Google. CONTENT: More than 18 types of amino acid repeats were identified from the PfHRP2 sequences. Sequencing analysis revealed high-level genetic variation in the pfhrp2 and pfhrp3 genes (>90% of variation in Madagascar, Nigeria or Senegal) both within and between countries. However, genetic variation of PfHRP2 and PfHRP3 does not seem to be a major cause of false-negative results. The countries that showed the highest proportions of pfhrp2-negative parasites were Peru (20%-100%) and Guyana (41%) in South America, Ghana (36%) and Rwanda (23%) in Africa. High prevalence of pfhrp2 deletion causes a high rate of false-negatives results. IMPLICATIONS: Presence of parasites lacking the pfhrp2 gene may pose a major threat to malaria control programmes because P. falciparum-infected individuals are not diagnosed and properly treated.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Gendrot M, Fawaz R, Dormoi J, et al. Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria. Clin Microbiol Infect. 2018. PMID: 30267926. doi:10.1016/j.cmi.2018.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。